Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Magnesium channels and transporters are a diverse group of membrane proteins responsible for maintaining magnesium (Mg2+) homeostasis across cellular and organellar membranes [NIH, 2022]. As the second most abundant intracellular cation, magnesium is essential for over 300 enzymatic reactions, including ATP-dependent processes, DNA/RNA synthesis, and protein translation [StatPearls, 2023]. Key members of this group include the transient receptor potential melastatin 6 and 7 (TRPM6/7) chanzymes, which possess both ion channel and kinase domains, the solute carrier family 41 (SLC41) transporters, the magnesium transporter 1 (MagT1), and the mitochondrial RNA splicing 2 (MRS2) protein [MDPI, 2021; UniProt]. These proteins facilitate Mg2+ flux through various mechanisms, including passive diffusion down electrochemical gradients, active transport, and Na+/Mg2+ exchange [Wikipedia, 2024]. Dysregulation of these transporters is linked to various pathologies, including renal magnesium wasting, cardiovascular diseases, neurodegenerative disorders like Parkinson's, and several types of cancer where TRPM7 often promotes tumor progression [Nature Reviews Cardiology, 2017; PubMed, 2021]. Therapeutic strategies involve the use of magnesium supplements to restore levels or small-molecule inhibitors like TG100-115 and NS8593 to target specific channels in inflammatory and oncological contexts [MDPI, 2025; PubMed, 2022].
Direct inhibition of ion-conducting pores, inhibition of C-terminal alpha-kinase activity, competitive substrate supplementation, and modulation of Na+/Mg2+ exchange stoichiometry.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Magnesium channel and transporter (Mg2+ transporter).